Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis

• Main Authors: Wenhai Fu (Author), Wenjun He (Author), Yuexin Li (Author), Yangxiao Chen (Author), Jingyi Liang (Author), Hui Lei (Author), Lin Fu (Author), Yanghang Chen (Author), Ni Ren (Author), Qian Jiang (Author), Yi Shen (Author), Ran Ma (Author), Tao Wang (Author), Xinni Wang (Author), Nuofu Zhang (Author), Dakai Xiao (Author), Chunli Liu (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Pulmonary arterial hypertension (PAH) is a severe and fatal clinical syndrome characterized by high blood pressure and vascular remodeling in the pulmonary arterioles, which is also a rapidly progressing disease of the lung vasculature with a poor prognosis. Although PAH medication made...